BioCatSyn (Shanghai) Biotechnology Co., Ltd. was established in 2022, led by Professor Wei Dongzhi - the founder of the Newworld Institute of Biotechnology. The company aims to become a global provider of cutting-edge synthetic biology technology, products, and solutions. It has created three major technical platforms: "Enzyme and Biocatalysis," "Cell Factory and Biosynthesis," and "Process Engineering." The company has completed an initial round of financing worth tens of millions of yuan, led by well-known investment institutions.
BioCatSyn is located in Nanqiao Science and Technology Town, Lingang, Shanghai (the core area of Fengxian New Town), with nearly 2000 square meters of R&D and office space. The company's business will be directed towards the application fields of medicine, food, cosmetics, agriculture, bio-based chemicals, etc. It is committed to the research and application of green biological manufacturing of related products, and will promote the development and production of various biocatalytic and biosynthetic pipeline products. It has reached strategic cooperation agreements with well-known domestic and foreign pharmaceutical, chemical, and other enterprises.
